Kiribati vs Myanmar: Cause of death, by non-communicable diseases, ages 0-4, male
Kiribati
13.5%
in 2021
Myanmar
13.2%
in 2021
Kiribati rank
135th
Myanmar rank
136th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Kiribati
- Myanmar
How they compare
Kiribati currently reports 13.5% against 13.2% in Myanmar, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Kiribati ahead.
Kiribati ranks 135th and Myanmar ranks 136th of 185 countries.
Across the 3 decades both report, Kiribati averaged higher in 2 and Myanmar in 1.
Head to head by decade
| Decade | Kiribati | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.7% | 10.0% | 1.6% | Kiribati |
| 2010s | 15.4% | 13.6% | 1.8% | Kiribati |
| 2020s | 14.4% | 14.4% | 0.0% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Kiribati or Myanmar?
- Kiribati, at 13.5% against 13.2% in Myanmar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Kiribati and Myanmar?
- 0.3%, with Kiribati ahead.
- How many years of comparable data are there for Kiribati and Myanmar?
- 6 years are reported by both, from 2000 to 2021.
- How do Kiribati and Myanmar rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Kiribati ranks 135th and Myanmar ranks 136th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.